Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy (Q33186072)

23 July 2017

1 reference

title

Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy (English)

1 reference

23 July 2017

0 references

H Fukuzako

1

1 reference

23 July 2017

1 April 2001

1 reference

World Journal of Biological Psychiatry

23 July 2017

1 reference

23 July 2017

2

1 reference

23 July 2017

2

1 reference

23 July 2017

70-82

1 reference

Elementary phenotypes in the neurobiological and genetic study of schizophrenia

23 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Increased temporal lobe glucose use in chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Localized NMR spectroscopy in vivo. Progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Phosphorus magnetic resonance spectroscopy in schizophrenia: correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Haloperidol improves membrane phospholipid abnormalities in temporal lobes of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Increased platelet phospholipase A2 activity in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Brain function in psychiatric disorders. III. Regional cerebral blood flow in unmedicated schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Fatty acid levels in the brains of schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Phosphorus-31 MR spectroscopic imaging (MRSI) of normal and pathological human brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

No differences in phospholipase-A2 activity between acute psychiatric patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Phosphorus 31 Magnetic Resonance Spectroscopy Detects Altered Brain Metabolism Before Onset of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Biological correlates of slow wave sleep deficits in functional psychoses: 31P-magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Spin-spin relaxation of the phosphodiester resonance in the 31P NMR spectrum of human brain. The determination of the concentrations of phosphodiester components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31P-NMR study of brain phospholipid structures in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Inhibition of antagonist and agonist binding to the human brain muscarinic receptor by arachidonic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Dinucleotide repeat polymorphism in the neurotrophin-3 gene and hippocampal volume in psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Patterns of cerebral blood flow in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Quantitative 31P MRS of the normal adult human brain. Assessment of interindividual differences and ageing effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

In vivo magnetic resonance spectroscopy. Applications in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Uniting Kraepelin and Bleuler: the psychology of schizophrenia and the biology of temporal lobe abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

MRI anatomy of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Chemical and physiologic brain imaging in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Potentiation of NMDA receptor currents by arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

The role of immune function in schizophrenia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Elevated PLA2 activity in schizophrenics and other psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Effect of photic stimulation on human visual cortex lactate and phosphates using 1H and 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Frontal lobe phosphorus metabolism and neuropsychological function in aging and in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Correlation of third ventricular enlargement and EEG slow wave activity in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Phosphorus-31 magnetic resonance spectroscopy in humans by spectroscopic imaging: localized spectroscopy and metabolite imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Magnetic resonance spectroscopy and schizophrenia: what have we learnt?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Lipids and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Heritability of BDNF alleles and their effect on brain morphology in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

31P magnetic resonance spectroscopy studies in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Meta-analysis of regional brain volumes in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

Genetic variant near cytosolic phospholipase A2 associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622970109027496

10.3109/15622970109027496

21 January 2018

Identifiers

DOI

1 reference

23 July 2017

1 reference

PubMed ID

12587188